Overview

Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
if amifampridine can improve neuromuscular transmission in muscles previously injected with OnabotulinumtoxinA (BTX-A)
Phase:
Phase 1
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Amifampridine